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Abstract
Although treatment fidelity strategies for enhancing the integrity of behavioral interventions have
been well described, little has been written about monitoring data collection integrity. This article
describes the principles and strategies developed to monitor data collection integrity of the
“Stories and Music for Adolescent/Young Adult Resilience During Transplant” study
(R01NR008583; U10CA098543; U10CA095861) — a multi-site Children’s Oncology Group
randomized clinical trial of a music therapy intervention for adolescents and young adults
undergoing stem cell transplant. The principles and strategies outlined in this article provide one
model for development and evaluation of a data collection integrity monitoring plan for behavioral
interventions that may be adapted by investigators and may be useful to funding agencies and
grant application reviewers in evaluating proposals.
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Introduction
In 1999, the National Institutes of Health (NIH) established the Behavioral Change
Consortium (BCC) to foster collaboration by researchers across 15 research projects that had
been funded to evaluate behavior-change interventions in various populations (Ory, Jordan,
& Bazzarre, 2002). As the group began working together, members quickly recognized there
were several unique issues in the design and implementation of behavioral intervention
studies. Since that time, the Treatment Fidelity Workgroup of the NIH BCC has placed
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special emphasis on identifying treatment fidelity strategies for behavioral interventions
(Bellg et al., 2004; Borrelli et al., 2005). Treatment fidelity refers to: (a) maintaining the
integrity of an intervention and (b) developing procedures to ensure that the intervention is
evaluated appropriately (Bellg et al., 2004; Borrelli et al., 2005). Data collection and
management procedures play a role in ensuring that an intervention is evaluated
appropriately. The Treatment Fidelity Workgroup has thoroughly described specific
treatment fidelity concepts and strategies for enhancing the integrity of behavioral
interventions (Bellg et al., 2004; Borrelli et al., 2005). However, the principles and strategies
for assuring the integrity of data collection obtained in behavioral interventions have not
been as well described nor have those for the interventions themselves.
The NIH (1998) requires the establishment of a comprehensive plan for monitoring data and
patient safety for all clinical trials that entail potential risk to participants (http://
grants.nih.gov/grants/guide/notice-files/not98-084.html). According to the NIH Policy for
Data and Safety Monitoring, each Institute or Center is responsible for ensuring that its
sponsored clinical research activities have an appropriate plan for data and safety
monitoring. Often the Institute or Center delegates responsibility to the principal investigator
for developing and implementing a data safety and monitoring plan. Although the directive
for developing and implementing a data collection integrity monitoring plan is clear, the
NIH policy does not include the “nuts and bolts” level of detail needed to guide principal
investigators in developing a plan or evaluating its effectiveness.
The purpose of this paper is to provide a detailed description of the principles and strategies
used to monitor data collection integrity in the study, “Stories and Music for Adolescent/
Young Adults Resilience during Transplant” (SMART) — a randomized clinical trial (RCT)
of a music therapy intervention for adolescents and young adults (AYA) undergoing stem
cell transplant (SCT) for cancer. In the following sections, we describe the: (a) features of
the SMART study that needed to be considered in the data collection integrity monitoring
plan; (b) principles guiding development of the plan; (c) specific strategies used; and (d)
helpfulness of strategies to address challenges.
SMART Study Features
In order to plan effectively for the monitoring of data collection integrity, a study’s design,
population, setting, personnel, and technology features all need to be carefully considered.
The SMART study is a relatively complex multi-site RCT of a behavioral music therapy
intervention and is supported through two NIH mechanisms — as both an RO1 from NINR
(R01NR008583) and a limited-site cooperative group study through the Children’s
Oncology Group (U10CA098543; U10CA095861). The SMART study complexities that
needed to be considered in developing a data collection integrity monitoring plan are
described here to provide readers with background about ways study features influence data
collection integrity planning decisions.
Design Features
The complexity of the design, including number of groups, measures, and times for data
collection are key features to consider when planning ways of obtaining accurate and
complete data. The two-group SMART study compared the efficacy of a therapeutic music
video intervention to a low-dose control group audio-books condition. Each group received
six, 60-minute sessions (two sessions per week, for 3 weeks). Data were collected over nine
discrete intervals (i.e., three major data collections: (a) at baseline, prior to transplant; (b)
post-intervention, usually 3 weeks post-transplant; (c) 100-days post-transplant; and six brief
pre-/post-session data collections: prior to and immediately following intervention sessions
2, 4, and 6). The major data collections, done via laptop computers connected to the Internet,
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involved the completion of 23 discrete self-report measures by the AYA and took 45
minutes to 2 hours to complete, as well as completion by parents or by AYA > 18 years of
age of additional demographic questions that took approximately 15 minutes to complete.
The pre-/post-session data collections involved five brief symptom measures together taking
5 to 7 minutes to complete. All data collection time points were completed either in an in-
patient or out-patient health care setting with the exception of the third major data collection
time point (i.e., 100 days post-transplant). Because most AYAs had been discharged home
by this time point, it would have been burdensome for AYA to return to the clinic.
Therefore, AYA were offered the option to complete the measures from home or from their
local follow-up site. In such cases measures were completed via the secure, password
protected data collection website, and the data collector was available throughout the session
via telephone.
Sample Features
The illness acuity and age of the study sample are also important to consider in planning for
data collection. The target sample for SMART was AYA with cancer, between the ages of
11 and 24, who were hospitalized for an SCT. Individuals undergoing SCT often experience
serious and debilitating side effects, and the transplant course can be quite unpredictable,
which makes AYAs’ ability to engage in intervention and data collection activities equally
unpredictable. The likelihood that AYAs would experience a high level of symptom distress
during their participation was high; the implications for subject burden and participation had
to be incorporated into both the clinical trial protocols and training for study team members.
In addition, while maintaining standardization of approaches, research members needed to
effectively interact with AYA across a wide developmental continuum: from pre-, middle,
and older adolescence to young adulthood.
Setting and Personnel Complexity
The SMART study was implemented in six different states in a combination of 11 pediatric
and adult hospital settings. Each study site had multiple team members serving in varied
roles and coming from multiple disciplines. At different times during the implementation of
the study, the research team consisted of 36 to 64 members from eight different disciplines/
areas of expertise (nursing, music therapy, biostatistics, medicine, public health, social work,
psychology, and certified research associates). Although the rich diversity of perspectives
among the multidisciplinary team members was highly beneficial, there were also different
levels of research knowledge and experience among team members. This variability
required planning to ensure a baseline standard for practice in study–related roles for all
team members.
Two roles were specific to the SMART study data collection: (a) data collectors —
individuals responsible for all data collection sessions related to the intervention — and (b)
quality assurance monitors — four trained staff located at the lead study site who evaluated
the audio-taped data collection sessions and provided feedback to the data collectors across
all sites. Each site had at least two data collectors. The majority of data collectors were
Certified Research Associates and members of the Children’s Oncology Group. Specific
details related to these roles are described under the section on strategies to monitor data
collection integrity.
Data Collection Features
When planning data collection integrity monitoring strategies, the procedures for data
collection need to be considered because these procedures can affect how well evaluators are
blinded, how burdensome data collection is, and how consistently data collection procedures
are implemented. A customized, password-protected, web-based data management system
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was created for the SMART study. This system was developed by two data managers
assigned to our team from the Department of Biostatistics at the core site. The SMART
study’s multi-leveled data collection and monitoring website included: participant data
collection; self-evaluated quality assurance monitoring for both the data collector and
interventionist roles; data collection and intervention monitor-assessed quality assurance;
patient scheduling; and tracking modules (Musik et al., in press). Each of these secure
components of the website required role-specific access permission.
Study-related data, including data specific to quality assurance monitoring, were captured in
real time. AYA data were collected via laptop computers that had multiple levels of security
protections within and across sites (e.g., implementation of port blocking and Internet
Protocol filters to limit network access; utilization of secure database server that concealed
its data storage location; and encryption of data between the web server and participants;
Musik et al., in press). Electronic backup copies were created and stored nightly.
Before study implementation, the AYA data collection website was evaluated by members
of a teen advisory board at one of the participating institutions, and the website was revised
and integrated into the final product based on their feedback. To ensure minimal missing
data, the data collection website contained cues (i.e., a tone sounded and a message
appeared) for both AYAs and data collector to review data collection for completeness.
In addition to the SMART website, the study team used Indiana University’s collaboration
and learning website (Oncourse CL) that allowed members to securely exchange
information between sites and communicate with other members of the team. Information
about the protocols, study roles, and minutes from meetings were housed in this password-
protected site. The use of this additional web-based portal facilitated communication
between geographically distant sites in real time. It also enhanced access at all times to the
most current study-related materials by all team members.
Guiding Principles
To ensure that all of the above complexities were addressed, six principles guided the
development and implementation of our data collection integrity monitoring plan:
1. A comprehensive data collection approach — the delivery and format of the
measures to the AYA and family needed to be consistent, thorough, and according
to protocol.
2. Competency and consistency in the use of technology — both the AYA and data
collector were competent and consistent in use of the technology.
3. Open communication — regular forums were established for all members of the
data collection team to ask questions, share data collection experiences, and receive
constructive feedback.
4. Systematic, multi-level, and multi-source tracking of processes and accountability
— an organized approach to monitoring and documenting how data were collected
and ensuring data collectors were accountable for following the established
protocols.
5. Transparency of processes used by all team members — all aspects of the
evaluation process were transparent and systematically evaluated by quality
assurance monitors
6. Growth and learning opportunities for all team members — opportunities were
available for team members to grow and learn from their experiences as a data
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collector or monitor. These six principles guided the data collection integrity
processes designed and implemented for the study.
Strategies to Monitor Data Collection Integrity
The guiding principles were operationalized in four ways. These included standardized data
collection protocols and manuals, standardized training, on-going team communication, and
on-going quality assurance monitoring. Table 1 summaries the guiding principles and
strategies used to address each principle.
Standardized Data Collection Protocols and Manuals
During our pilot study to assess feasibility and acceptability of the SMART study, we
developed the preliminary data collection protocols. Over the course of data collection with
12 AYAs, word-for-word scripts and other data collection procedures were systematically
developed based on the insights and feedback of the graduate-level research assistant
involved in collecting the data. Once funding was obtained for the larger study, the word-
for-word scripts and step-by-step procedures were expanded, evaluated, refined in a group
process, and used as the basis of the data collection protocol.
Table 2 shows a portion of the scripted data collection protocol, outlining the first three
steps for the data collector. Under each step of the protocol, the processes were described in
detail. For example, under the second heading, “Creating the Data Collection Environment,”
the specifics about introducing oneself to the AYA and family and beginning the audio
recording were outlined. Additionally, word-for-word scripts were provided in areas where
consistent information needed to be given to the AYAs. For example, under the third
heading, “Give Brief Review of Data Collection Procedures,” a word-for-word script was
provided so all AYAs would know what to expect during the session. Until data collectors
became familiar with the content and wording, they informed the AYAs that they would be
reading some of the instructions to make sure everyone in the study had the same
information.
During the start-up phase of the study, standardized manuals were developed to ensure
organized and consistent information was provided during training and readily available
post-training. The purpose of the manuals was to ensure that all team members had
comprehensive handbooks containing consistent, accurate, and accessible information about
the SMART study. Three separate manuals were created that were specific to roles of
project manager/site PI, interventionist, and data collector. The study manual for data
collectors included: (a) background of the study development and funding sources; (b)
organizational structure and team members; (c) overview of conceptual frameworks guiding
the study; (d) brief descriptions of intervention arms; (e) policy and procedures; (f) disease
and treatment clinical considerations; (g) job description; (h) description of instruments; (i)
data collection protocols; and (j) quality assurance forms. Because data collectors were
blinded to the AYA’s group assignment, only basic information, to ensure “buy-in”, related
to the intervention and control conditions (i.e. making a DVD and listening to books on
tapes) was included in the manual.
Standardized Training
All study team members participated in comprehensive standardized training, completed
over two days. Training included a thorough review of all of the components of the
standardized training manual described above. Additionally, team-building activities, role-
playing exercises, technology training and procedures for blinding were incorporated into
training.
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Team-building activities were essential to establish a level of confidence in and cooperation
among team members. During the 2-day face-to-face training session that took place at the
core study site, time was scheduled for introductions, opportunities to visit with other team
members during breaks, and shared meals. These opportunities allowed the data collectors
and others to get to know the study leadership and each other prior to the implementation of
the study. Team-building activities enabled members to gain comfort, rapport, and a sense of
collegiality with each other that was especially valuable during the role-playing scenarios
used during training.
Data collectors received role-specific training and participated in role-playing exercises that
addressed potential situations that might be encountered during a data collection session. For
example, one role-playing exercise focused on how to manage interruptions. The role-
playing component provided the trainers the opportunity to evaluate the skill level of each
data collector and offer anticipatory guidance, thus increasing both data collector comfort
with approaching AYAs during a stressful time and ensuring successful data collection.
Role-playing was particularly important because most of the data collectors had limited
experiences interacting directly with AYAs.
Data collectors received hands-on training on how to navigate study-related website systems
for data collection and monitoring. This training took place in a computer lab and gave data
collectors the chance to access and view the websites they would be using during the study.
Data collectors were also given instructions on how to access the required post-session
quality assurance forms (i.e., the Self Quality Assurance Form and Field Notes) on the
monitoring website.
The importance of ensuring that data collectors remained blinded to each AYA’s group
assignment was emphasized during training. Data collectors were informed of the rationale
for blinding, provided information about how to report unblinding occurrences, and given
examples of situations in which unblinding could potentially occur. Additionally, within the
protocol dialogue for each data collection session, the data collector was prompted to remind
the AYA not to reveal what group s/he was randomized to. Other strategies to ensure that
blinding was maintained included: (a) developing different websites for data collectors and
interventionists for communication purposes; (b) having data collectors wear buttons that
said, “I’m an Evaluator! Please don’t tell me what group you are in”; (c) providing
information to staff on the SCT units about the study and their role in helping the research
team maintain blinding of the data collectors; and (d) placing a study-related care plan in the
AYA’s chart that included encouragement for staff to avoid discussing the study with data
collectors.
Ongoing Team Communication
Ongoing communication and training for data collectors occurred predominantly through
regularly scheduled conference calls. The primary purposes for these conference calls were
to: (a) provide opportunities for data collectors to share their experiences; (b) facilitate
consistent communication; (c) promote group participation in problem solving; and (d)
enhance data collectors’ commitment to the study. A dedicated toll-free phone number was
used for these conference calls. Email reminders were sent to data collectors at least 3 days
ahead of the scheduled call time to ensure that the meeting was incorporated into team
members’ busy schedules. Each site had between two to four data collectors at any given
time; on average 90% attended the conference calls.
To further facilitate ongoing communication among study team members, the OnCourse CL
website described above was used to post and archive announcements and other information
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related to data collection, examples of role-playing exercises, team members’ contact
information, and electronic copies of the data collection protocol.
Quality Assurance Monitoring
Quality assurance monitoring was another strategy used to ensure the integrity of the data
collected. Data collectors were required to digitally record all of their data collection
sessions. Within 24 hours of a session, data collectors listened to their recorded session and
completed the self quality assurance evaluation checklist on the SMART study monitoring
website.
To ensure that the data collection was carried out according to protocol and that the data
collection was a positive experience for the AYA, the designated quality assurance monitor
reviewed the data collector’s field notes and the session’s audio-recording for compliance
with the protocol. The quality assurance monitor then completed the same quality assurance
evaluation checklist as the data collector and provided positive and constructive feedback to
the data collector. Competency within a session was achieved when all items on the
checklist were marked “done.” or the item was marked “not appropriate” if a reason could
be provided indicating why an action could or should not have been completed (e.g., asking
the AYA’s family to leave the room when they were not in the room). The feedback was
provided to data collectors for the first three long data collections and the first three pre/post
data collection sessions they completed. If there were no significant problems (e.g., missing
important actions; failing to complete checklist and field notes in a timely matter, or failing
to provide a full narrative description of deviations from protocol), the data collector was
considered competent for data collection study procedures. Inconsistencies, problems with
inaccuracies, or deviations from the protocol were discussed with the data collector
individually. When appropriate, the lessons learned were shared by the data collector on
subsequent data collection team calls, so all data collectors could benefit. After each data
collector reached competency, the data collector was no longer required to complete the
checklist; however, 20% of their subsequent data collection events were randomly selected
for review using the same procedures for evaluating protocol adherence.
Helpfulness of Strategies to Address Ongoing Challenges
Inevitably, challenges arise when implementing a behavioral RCT. Data collection integrity
monitoring strategies developed for the SMART study assisted the research team to identify
and effectively address challenges in a timely manner. Specific challenges that arose during
the course of the SMART study were related to technology, cancelled sessions, and
interruptions of data collection sessions by others. To help anticipate challenges, we provide
specific description of some challenges that arose and strategies used to address them
Technology Issues
Especially during the study start-up phase, technology issues occasionally influenced timing,
completeness, and quality of data, and had the potential to influence the interest and
engagement of the AYA to complete study measures. Technology challenges included
interfacing the information technology across multiple hospitals and university systems,
where varied security systems and access rules were in place. A second challenge was loss
of wireless connection during data collection. This was distressing to both the AYA and the
data collector. To address this problem, paper copies of the exact computer screen shots of
the measures were made readily available; these paper copies were presented to AYA in the
same order as the computer and included the screen shots of encouraging messages. The
AYA were given 1/3 of the measures at a time; when these were completed, the data
collector exchanged the completed 1/3 of the measures for the next 1/3 and reviewed the
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completed measures for missing items, at the same time the AYA was finishing the next
section. Data from these paper copies were then manually entered into the data management
system by the site’s project manager within one hour after the data collection session and
checked for accurate entry. After realizing the potential for connectivity problems, data
collection protocols were revised to instruct data collectors to access the wireless connection
prior to entering the AYA’s room. When evaluation was done remotely, prior to the
scheduled evaluation time, the project managers worked with the AYAs to assure they knew
how to connect. This resulted in decreased anxiety for both the AYAs and data collectors.
For the rare times when connectivity problems could not be resolved quickly, the available
paper copies of the study measures were used. This ensured consistency and timeliness even
with the inevitable occasional technological challenges.
Scheduling Data Collection Sessions
Scheduling evaluation sessions was a challenge for various reasons, including high levels of
AYA symptom distress, competing scheduled treatments, and competing AYA activity
priorities. These data collection scheduling challenges were primarily related to cancelled
intervention sessions. Depending on the level of symptom distress, the AYA was either
encouraged to “try” the session and stop if they continued to feel ill, or the session was
rescheduled. To further address the challenge of symptoms, strategies for assessing the
situation (i.e., communicating appropriately with the AYA) and coordinating with project
managers were reinforced during training and conference calls. Competing treatments were
addressed by deliberatively working to get nursing staff buy-in to the significance of the
study and working closely with them to identify optimal times for AYAs to complete the
evaluations. Project managers also worked closely with the AYAs to assure the evaluation
sessions were worked in around their other activity priorities. Missing data collection
sessions were automatically tracked through a report of timeliness of all study activities that
was generated in real time in the data management system.
Interruptions of Data Collection Sessions by Others
Interruptions from family members, especially parents, and healthcare providers were
inevitable, even though each received information about the need for a quiet, non-
distracting, comfortable environment in order to ensure that the AYA could thoughtfully and
independently complete measures. Challenges included side conversations by/with parents if
they decided not to leave during data collection, distracting noises from televisions and IV
pumps, and other visitors entering the room. Data collectors developed and shared their
repertoire of successful strategies to manage distractions with each other. In order to
minimize preventable distractions, we provided regular in-services at each site to ensure
clinical staff knew about the study and how they could contribute to its success. However,
the inevitability of interruptions by clinical staff for medically necessary treatments was
acknowledged. Project managers worked closely with the nursing staff to keep the study-
related activities visible on the units.
Conclusion and Recommendations
The guiding principles and strategies of the SMART study’s data collection integrity
monitoring plan provide one model that may be useful to investigators planning to evaluate
a behavioral intervention across multiple sites. The following are our summary
recommendations.
First, whenever possible, investigators should consider taking the time to plan the essential
components of their data collection integrity monitoring plan during pilot work. For our
research team, the pilot study provided essential groundwork for developing our data
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collection integrity monitoring plan. The pilot study provided the opportunity to consider the
ways unique features of the study would influence how data were collected and guided the
specific steps needed to administer the instruments. The development of the word-for-word
scripts and step-by-step procedures helped us create a consistent data collection approach
that could easily be evaluated. Several of the data collectors in the larger study reported that
they found the scripts and procedures to be extremely helpful, particularly if they had not
had previous experiences in interacting with AYAs with cancer. The step-by-step
procedures also helped eliminate any deviations from the protocol. Other benefits gained
from the pilot study included the opportunity to create realistic role-playing exercises that
were useful during the standardized training and the development of the standardized
procedure for evaluating each data collection session.
The second recommendation is to ensure that data collectors have the opportunity to
establish and maintain rapport and open communication with one another, quality assurance
monitors, and core team leaders. In the SMART study, the standardized training session
helped data collectors understand how they uniquely contributed to the study while
introducing and connecting them with the other team members. This rapport, maintained
through regularly scheduled conference calls, provided a non-threatening forum to openly
discuss problems and share ideas about how to deal with difficult situations. The
combination of both electronic and personal communication provided a unique, accessible
support and feedback mechanism among data collectors, quality assurance monitors, and site
core investigators. Our data collectors reported that the extensive communication
opportunities resulted in a much stronger commitment to the study than they had commonly
experienced when working with other clinical trials. For some data collectors, their
commitment was so strong that they willingly took an active role in participating in
dissemination of study results (Lee et al., 2008).
Our third recommendation is to develop a data collection integrity monitoring plan that is
well-organized and structured. The organization and structure of the SMART study’s data
collection integrity monitoring plan were imperative in ensuring the components of the plan
were carried out appropriately. We maintained this organization and structure through the
use of technology. The website monitoring system, for example, was essential in keeping
track of any discrepancies related to data collection. If problems arose, the site projector
coordinator could quickly resolve them. The use of Oncourse also helped provide
organization by having an easily accessible secure website for data collectors to access the
manuals and protocols and posting of meeting minutes.
The fourth recommendation is to use technology to minimize data collection burden and
error. Despite the fact that technology problems inevitably occurred, the use of technology
was clearly welcomed by our participants and study team members. For most AYAs,
completing data collection on the computer was more comfortable and quickly
accomplished than with paper- and-pencil format. In addition, the ability to directly upload
data to the secure website server as the AYA completed the measures decreased the risk of
error and saved time and effort for data collectors. The convenience of remote, secure data
collection was particularly helpful at Time 3 when many AYAs were home and able to
complete data collection without making a trip to the study site.
The fifth recommendation is to consider partnering with cooperative groups to enhance data
collection integrity. The Children’s Oncology Group enhanced our data collection integrity
efforts in several ways: assuring all participants were registered thorough the Children’s
Oncology Group’s national database, having skilled Certified Research Associates available
on-site to assist with data collection, and having the same disease and treatment-related
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forms used by the Children’s Oncology Group and entered by the Certified Research
Associates.
Based on the implementation of the principles and strategies described in this article, we
conclude that a comprehensive data collection integrity monitoring plan in a multi-site
behavioral intervention is necessary to ensure that proper documentation of the data
collection process is organized in a coherent manner, facilitate data analysis, add credibility
to findings, and ensure that the quality of care provided to participants is consistent with the
established standards. Other process features of a data collection integrity monitoring plan
include: (a) generating regular reports of data quality for distribution to appropriate team
members; (b) identifying and correcting problems by developing case studies for ongoing
education; and (c) creating a final report of all quality assurance efforts, including protocol
adherence and deviations, for use during the interpretation of findings. In addition to these
process features, our plan included standardized training of all study personnel; the use of
database tracking of recruitment, accrual, and retention; and a two-level process for
identification of adverse events.
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Table 1
Guiding Principles and Strategies Used to Address Each Principle
Guiding Principle Strategies Used
Comprehensive data collection approach — the delivery and
format of the measures to the AYA and family needed to be
consistent, thorough, and according to protocol
Standardized Data Collection Protocols and Manuals
Standardized Training
Quality Assurance Monitoring
Competency and consistency in the use of technology — both
the AYA and data collector were competent and consistent in
use of the technology
Standardized Training
Quality Assurance Monitoring
Open communication — regular forums were established for
all members of the data collection team to ask questions, share
data collection experiences, and receive constructive feedback
Standardized Training
Ongoing Team Communication
Quality Assurance Monitoring
Systematic, multi-level, and multi-source tracking of processes
and accountability — an organized approach to monitoring
and documenting how data were collected and ensuring data
collectors were accountable for following the established
protocols
Ongoing Team Communication
Quality Assurance Monitoring
Transparency of processes used by all team members — all
aspects of the evaluation process were transparent and
systematically evaluated by quality assurance monitors
Standardized Data Collection Protocols and Manuals
Quality Assurance Monitoring
Growth and learning opportunities for all team members —
opportunities were available for team members to grow and
learn from their experiences as a data collector or monitor
Ongoing Team Communication
Quality Assurance Monitoring
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Table 2
Portion of Scripted Data Collection Protocol
Session 2
I. Before entering the room
1. Arrive 5 to 10 minutes before the scheduled session.
2. …
II. Creating the Data Collection Environment
1. On entering the room, introduce or re-introduce yourself to the adolescent/young adult and his/her family member(s).
2. Show the adolescent/young adult the digital recorder.
3. Remind the adolescent/young adult and family that the data collection session will again be audio-recorded for quality
assurance purposes.
4. ….
III. Give Brief Review of Data Collection Procedures
1. Explain to the adolescent/young adult and family what will be happening over the next hour or so:
• “During this data collection session, we will be collecting data only from (name of adolescent/young
adult). (Name of adolescent/young adult) will complete the same longer set of questionnaires on the
laptop as the first time, which will take about 45 to 60 minutes to complete.”
• “To give (name of adolescent/young adult) a quiet environment, free from distraction, before we
actually begin data collection, I will ask the family and friends to wait outside and place a “Do Not
Disturb” sign on the door.”
Res Nurs Health. Author manuscript; available in PMC 2012 August 01.
